STOCK TITAN

Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
buybacks management dividends

Chemed (NYSE:CHE) has announced two significant financial decisions: First, its Board of Directors has authorized an additional $300 million for stock repurchase under the existing share repurchase program, to be funded through operational cash flow and revolving credit facility. Second, the board declared a quarterly cash dividend of 50 cents per share, payable on December 6, 2024, to shareholders of record as of November 18, 2024. This marks Chemed's 214th consecutive quarterly dividend in its 53-year history as a public company.

Chemed (NYSE:CHE) ha annunciato due importanti decisioni finanziarie: in primo luogo, il suo Consiglio di Amministrazione ha autorizzato un ulteriore 300 milioni di dollari per il riacquisto di azioni nel quadro del programma di riacquisto azioni esistente, che sarà finanziato tramite flusso di cassa operativo e linea di credito rotativa. In secondo luogo, il consiglio ha dichiarato un dividendo in contante trimestrale di 50 centesimi per azione, che sarà pagato il 6 dicembre 2024, agli azionisti registrati al 18 novembre 2024. Questo segna il 214° dividendo trimestrale consecutivo di Chemed nella sua storia di 53 anni come società pubblica.

Chemed (NYSE:CHE) ha anunciado dos decisiones financieras significativas: en primer lugar, su Junta Directiva ha autorizado 300 millones de dólares adicionales para recompra de acciones bajo el programa existente, que se financiará a través del flujo de efectivo operativo y la línea de crédito rotativa. En segundo lugar, la junta declaró un dividendo en efectivo trimestral de 50 centavos por acción, que se pagará el 6 de diciembre de 2024, a los accionistas registrados a partir del 18 de noviembre de 2024. Esto marca el 214° dividendo trimestral consecutivo de Chemed en sus 53 años de historia como compañía pública.

Chemed (NYSE:CHE)는 두 가지 중요한 재정 결정을 발표했습니다. 첫째, 이사회는 기존 주식 매입 프로그램에 따라 3억 달러의 추가 주식 매입을 승인하였으며, 이는 운영 현금 흐름과 회전 신용 시설을 통해 자금 조달될 예정입니다. 둘째, 이사회는 주당 50센트의 분기 현금 배당금을 선언하였으며, 2024년 12월 6일에 2024년 11월 18일 기준 주주에게 지급될 예정입니다. 이는 공개 회사로서 53년 역사에서 Chemed의 214번째 연속 분기 배당금을 기록하는 것입니다.

Chemed (NYSE:CHE) a annoncé deux décisions financières importantes : tout d'abord, son conseil d'administration a autorisé un montant supplémentaire de 300 millions de dollars pour le rachat d'actions dans le cadre du programme de rachat d'actions existant, qui sera financé par le flux de trésorerie opérationnel et une ligne de crédit renouvelable. Deuxièmement, le conseil a déclaré un dividende trimestriel en espèces de 50 cents par action, payable le 6 décembre 2024, aux actionnaires inscrits au 18 novembre 2024. Cela marque le 214e dividende trimestriel consécutif de Chemed dans ses 53 années d'histoire en tant qu'entreprise publique.

Chemed (NYSE:CHE) hat zwei bedeutende finanzielle Entscheidungen bekannt gegeben: Erstens hat der Vorstand eine zusätzliche Genehmigung von 300 Millionen Dollar für den Aktienrückkauf im Rahmen des bestehenden Aktienrückkaufprogramms erteilt, das durch operative Geldflüsse und eine revolvierende Kreditfazilität finanziert wird. Zweitens hat der Vorstand eine vierteljährliche Bar-Dividende von 50 Cent pro Aktie erklärt, die am 6. Dezember 2024 an die Aktionäre ausgezahlt wird, die am 18. November 2024 in den Büchern stehen. Dies markiert die 214. aufeinanderfolgende vierteljährliche Dividende von Chemed in seiner 53-jährigen Geschichte als öffentliches Unternehmen.

Positive
  • Authorization of $300 million additional stock repurchase program
  • Maintained quarterly dividend of 50 cents per share
  • 214th consecutive quarterly dividend payment, showing consistent shareholder returns
  • Multiple funding sources available for share repurchases
Negative
  • Potential increase in debt through utilization of revolving credit facility for buybacks

Insights

The $300 million stock buyback authorization significantly strengthens Chemed's capital return program, representing approximately 3.6% of its current market capitalization. This move, combined with the consistent quarterly dividend of $0.50 per share, demonstrates robust financial health and commitment to shareholder returns. The company's dual revenue streams from VITAS Healthcare and Roto-Rooter provide stable cash flow to support these initiatives. The use of revolving credit alongside operational cash indicates strategic financial planning, though investors should monitor the debt levels. The 214-quarter dividend streak highlights exceptional financial stability and reliable income potential for long-term investors.

CINCINNATI--(BUSINESS WIRE)-- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed’s existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.

The Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on December 6, 2024, to shareholders of record as of November 18, 2024. This is equal to the dividend paid in August 2024. This represents the 214th consecutive quarterly dividend paid by Chemed in its 53 years as a public company.

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.

Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

Michael D. Witzeman

(513) 762-6714

Source: Chemed Corporation

FAQ

How much additional stock repurchase did Chemed (CHE) authorize in 2024?

Chemed's Board of Directors authorized an additional $300 million for stock repurchase under its existing share repurchase program.

What is Chemed's (CHE) quarterly dividend amount for December 2024?

Chemed declared a quarterly cash dividend of 50 cents per share, payable on December 6, 2024, to shareholders of record as of November 18, 2024.

How will Chemed (CHE) fund its new stock repurchase program?

Chemed will fund the share repurchases through a combination of cash generated from operations and utilization of its revolving credit facility.

How many consecutive quarterly dividends has Chemed (CHE) paid?

Chemed has paid 214 consecutive quarterly dividends in its 53 years as a public company.

Chemed Corporation

NYSE:CHE

CHE Rankings

CHE Latest News

CHE Stock Data

8.28B
14.67M
2.13%
96.77%
1.73%
Medical Care Facilities
Services-home Health Care Services
Link
United States of America
CINCINNATI